- Stocks
- Healthcare
- NASDAQ: CNMD

Price (delayed)

$142.26

Market cap

$4.14B

P/E Ratio

309.26

Dividend/share

$0.8

EPS

$0.46

Enterprise value

$4.85B

The stock's price to earnings (P/E) is 82% less than its last 4 quarters average of 1739.1 and 24% less than its 5-year quarterly average of 402.0

The company's debt fell by 5% YoY

CNMD's EPS has shrunk by 61% YoY but it is up by 39% QoQ

The net income has dropped by 60% year-on-year but it is up by 41% since the previous quarter

CNMD's quick ratio is down by 8% YoY

CNMD's gross margin is down by 3.1% YoY

What are the main financial stats of CNMD

Market
Valuations
Earnings

Shares outstanding

29.09M

Market cap

$4.14B

Enterprise value

$4.85B

Price to earnings (P/E)

309.26

Price to book (P/B)

5.67

Price to sales (P/S)

4.68

EV/EBIT

92.06

EV/EBITDA

68.46

EV/Sales

5.5

Revenue

$881.13M

EBIT

$52.65M

EBITDA

$70.81M

Free cash flow

$73.08M

Per share
Balance sheet
Liquidity

EPS

$0.46

Free cash flow per share

$2.52

Book value per share

$25.07

Revenue per share

$30.41

TBVPS

$21.9

Total assets

$1.75B

Total liabilities

$1.02B

Debt

$745.4M

Equity

$725.57M

Working capital

$242.21M

Debt to equity

1.03

Current ratio

2.33

Quick ratio

1.1

Net debt/EBITDA

10.01

Margins
Efficiency
Dividend

EBITDA margin

8%

Gross margin

53.3%

Net margin

1.5%

Operating margin

6%

Return on assets

0.8%

Return on equity

1.9%

Return on invested capital

4.5%

Return on capital employed

3.4%

Return on sales

6%

Dividend yield

0.56%

DPS

$0.8

Payout ratio

173.9%

How has the CONMED stock price performed over time

Intraday

1.09%

1 week

-0.97%

1 month

9.05%

1 year

118.86%

YTD

27.02%

QTD

8.94%

How have CONMED's revenue and profit performed over time

Revenue

$881.13M

Gross profit

$469.59M

Operating income

$52.65M

Net income

$13.45M

Gross margin

53.3%

Net margin

1.5%

The net income has dropped by 60% year-on-year but it is up by 41% since the previous quarter

The company's net margin has shrunk by 57% YoY but it rose by 36% QoQ

The operating income has declined by 34% year-on-year but it has increased by 15% since the previous quarter

The operating margin has declined by 29% year-on-year but it has grown by 13% since the previous quarter

What is CONMED's growth rate over time

What is CONMED stock price valuation

P/E

309.26

P/B

5.67

P/S

4.68

EV/EBIT

92.06

EV/EBITDA

68.46

EV/Sales

5.5

The stock's price to earnings (P/E) is 82% less than its last 4 quarters average of 1739.1 and 24% less than its 5-year quarterly average of 402.0

CNMD's EPS has shrunk by 61% YoY but it is up by 39% QoQ

The stock's price to book (P/B) is 81% more than its 5-year quarterly average of 3.1 and 40% more than its last 4 quarters average of 4.0

CNMD's equity is up by 3.4% YoY and by 2.3% from the previous quarter

CNMD's P/S is 93% more than its 5-year quarterly average of 2.4 and 45% more than its last 4 quarters average of 3.2

CNMD's revenue is down by 7% year-on-year but it is up by 2.2% since the previous quarter

How efficient is CONMED business performance

CNMD's return on assets has surged by 60% since the previous quarter but it has dropped by 58% year-on-year

The ROE has plunged by 60% YoY but it has grown by 36% from the previous quarter

CNMD's return on invested capital is down by 32% year-on-year but it is up by 18% since the previous quarter

CNMD's ROS is down by 29% YoY but it is up by 13% QoQ

What is CNMD's dividend history

DPS

$0.8

Dividend yield

0.56%

Payout ratio

173.9%

Recent dividends

How did CONMED financials performed over time

CNMD's total assets is 71% greater than its total liabilities

CNMD's quick ratio is down by 8% YoY

The current ratio has grown by 6% from the previous quarter but it has contracted by 5% YoY

The company's debt is 2.7% higher than its equity

The company's debt to equity fell by 8% YoY and by 2.8% QoQ

The company's debt fell by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.